Method of purifying hepatitis A virus particles and vaccine preparation

Details for Australian Patent Application No. 2002358660 (hide)

Owner Baxter Healthcare S.A.

Inventors Barrett, Noel; Tauer, Christa; Meyer, Heidi; Mitterer, Artur

Agent Cullen & Co

Pub. Number AU-B-2002358660

PCT Number PCT/EP02/14008

PCT Pub. Number WO2003/049766

Priority 10/006,205 10.12.01 US

Filing date 10 December 2002

Wipo publication date 23 June 2003

Acceptance publication date 1 November 2007

International Classifications

C12N 15/09 (2006.01) Mutation or genetic engineering - Recombinant DNA-technology

A61K 39/29 (2006.01) Medicinal preparations containing antigens or antibodies - Hepatitis virus

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C12N 7/01 (2006.01) Viruses, e.g. bacteriophages - Viruses, e.g. bacteriophages, modified by introduction of foreign genetic material

C12N 7/02 (2006.01) Viruses, e.g. bacteriophages - Recovery or purification

Event Publications

3 April 2003 Complete Application Filed

  Priority application(s): 10/006,205 10.12.01 US

28 August 2003 Application Open to Public Inspection

  Published as AU-B-2002358660

1 November 2007 Application Accepted

  Published as AU-B-2002358660

28 February 2008 Standard Patent Sealed

7 July 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002358661-NOVEL AMIDINE DERIVATIVES AND THE USE OF THE SAME IN PHARMACEUTICALS

2002358659-Method for purifying a melamine melt